BCM
BML Capital Management Portfolio holdings
AUM
$131M
This Quarter Return
-9.69%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$137M
AUM Growth
+$137M
(-8.6%)
Cap. Flow
-$59.1M
Cap. Flow
% of AUM
-43.26%
Top 10 Holdings %
Top 10 Hldgs %
85.49%
Holding
35
New
3
Increased
9
Reduced
4
Closed
6
Top Buys
| 1 |
Adverum Biotechnologies
ADVM
|
$7.77M |
| 2 |
Aclaris Therapeutics
ACRS
|
$3.95M |
| 3 |
Atea Pharmaceuticals
AVIR
|
$2.78M |
| 4 |
Vanda Pharmaceuticals
VNDA
|
$2.25M |
| 5 |
Oramed Pharmaceuticals
ORMP
|
$1.3M |
Top Sells
Sector Composition
| 1 | Healthcare | 65.21% |
| 2 | Technology | 1.44% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares 0-3 Month Treasury Bond ETF
SGOV
$56.1B
| $27.2M | 19.4% | 270,000 | – | – |
|
|
2
Atea Pharmaceuticals
AVIR
$267M
| $21.1M | 15.06% | 6,375,621 +838,911 | +15% | +$2.78M |
|
3
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$42.1B
| $18.4M | 13.1% | 200,000 | – | – |
|
|
4
Aclaris Therapeutics
ACRS
$209M
| $14.3M | 10.2% | 12,988,134 +3,592,200 | +38% | +$3.95M |
|
|
5
Adverum Biotechnologies
ADVM
$64.6M
| $13.5M | 9.62% | 1,966,000 +1,132,883 | +136% | +$7.77M |
|
|
TECX
6
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
| $7.68M | 5.48% | 466,047 -3,535,580 | -88% | -$58.2M |
|
|
OKUR
7
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $4.04M | 2.88% | 2,672,194 +494,281 | +23% | +$746K |
|
8
Instil Bio
TIL
$182M
| $4.02M | 2.87% | 391,103 +42,368 | +12% | +$436K |
|
|
9
Oramed Pharmaceuticals
ORMP
$90.2M
| $3.47M | 2.47% | 1,349,038 +504,542 | +60% | +$1.3M |
|
|
CNTB
10
Connect Biopharma
CNTB
$115M
| $3.11M | 2.22% | 2,043,248 -18,090 | -0.9% | -$27.5K |
|
11
Athira Pharma
ATHA
$15.3M
| $2.39M | 1.7% | 900,000 | – | – |
|
|
12
Vanda Pharmaceuticals
VNDA
$279M
| $2.25M | 1.61% | +398,280 | New | +$2.25M |
|
13
PMV Pharmaceuticals
PMVP
$74.2M
| $2.12M | 1.51% | 1,309,397 +2,907 | +0.2% | +$4.71K |
|
14
Astrotech Corp
ASTC
$8.72M
| $1.96M | 1.4% | 220,410 | – | – |
|
15
Milestone Pharmaceuticals
MIST
$156M
| $1.46M | 1.04% | 1,102,895 +496,750 | +82% | +$656K |
|
16
Design Therapeutics
DSGN
$315M
| $1.41M | 1.01% | 421,749 -457,729 | -52% | -$1.53M |
|
17
Verrica Pharmaceuticals
VRCA
$52.8M
| $1.31M | 0.94% | 180,000 | – | – |
|
|
LENZ
18
LENZ Therapeutics
LENZ
$1.1B
| $1.11M | 0.79% | 63,916 | – | – |
|
19
Lisata Therapeutics
LSTA
$19.9M
| $988K | 0.7% | 284,669 | – | – |
|
|
IMA
20
ImageneBio, Inc. Common Stock
IMA
$150M
| $965K | 0.69% | +585,114 | New | +$965K |
|
21
Forte Biosciences
FBRX
$137M
| $946K | 0.68% | 1,761,702 | – | – |
|
22
CalciMedica
CALC
$37.7M
| $635K | 0.45% | 160,424 | – | – |
|
23
VistaGen Therapeutics
VTGN
$102M
| $522K | 0.37% | 150,000 | – | – |
|
|
ACHL
24
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
| $510K | 0.36% | +625,174 | New | +$510K |
|
25
NextCure
NXTC
$13.5M
| $440K | 0.31% | 276,465 -30,000 | -10% | -$47.7K |
|